88 related articles for article (PubMed ID: 22564758)
1. Naloxonazine, a specific mu-opioid receptor antagonist, attenuates the increment of locomotor activity induced by acute methamphetamine in mice.
Chien CC; Lee YJ; Fan LW; Ho IK; Tien LT
Toxicol Lett; 2012 Jul; 212(1):61-5. PubMed ID: 22564758
[TBL] [Abstract][Full Text] [Related]
2. The selective μ opioid receptor antagonist β-funaltrexamine attenuates methamphetamine-induced stereotypical biting in mice.
Kitanaka J; Kitanaka N; Hall FS; Uhl GR; Fukushima Y; Sawai T; Watabe K; Kubo H; Takahashi H; Tanaka K; Nishiyama N; Tatsuta T; Morita Y; Takemura M
Brain Res; 2013 Jul; 1522():88-98. PubMed ID: 23727404
[TBL] [Abstract][Full Text] [Related]
3. Deficits in behavioral sensitization and dopaminergic responses to methamphetamine in adenylyl cyclase 1/8-deficient mice.
Bosse KE; Charlton JL; Susick LL; Newman B; Eagle AL; Mathews TA; Perrine SA; Conti AC
J Neurochem; 2015 Dec; 135(6):1218-31. PubMed ID: 26146906
[TBL] [Abstract][Full Text] [Related]
4. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
[TBL] [Abstract][Full Text] [Related]
5. Enhanced Cdk5 activity and p35 translocation in the ventral striatum of acute and chronic methamphetamine-treated rats.
Chen PC; Chen JC
Neuropsychopharmacology; 2005 Mar; 30(3):538-49. PubMed ID: 15536496
[TBL] [Abstract][Full Text] [Related]
6. Dopamine D1 receptor-dependent modifications in the dopamine and cAMP-regulated phosphoprotein of Mr 32 kDa phosphorylation pattern in striatal areas of morphine-sensitized rats.
Scheggi S; Crociani A; De Montis MG; Tagliamonte A; Gambarana C
Neuroscience; 2009 Oct; 163(2):627-39. PubMed ID: 19559764
[TBL] [Abstract][Full Text] [Related]
7. Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity.
Itzhak Y; Gandia C; Huang PL; Ali SF
J Pharmacol Exp Ther; 1998 Mar; 284(3):1040-7. PubMed ID: 9495865
[TBL] [Abstract][Full Text] [Related]
8. Effects of the selective mu(1)-opioid receptor antagonist, naloxonazine, on cocaine-induced conditioned place preference and locomotor behavior in rats.
Rademacher DJ; Steinpreis RE
Neurosci Lett; 2002 Nov; 332(3):159-62. PubMed ID: 12399005
[TBL] [Abstract][Full Text] [Related]
9. Blockade of adenosine A2A receptors downregulates DARPP-32 but increases ERK1/2 activity in striatum of dopamine deficient "weaver" mouse.
Botsakis K; Pavlou O; Poulou PD; Matsokis N; Angelatou F
Neurochem Int; 2010 Jan; 56(2):245-9. PubMed ID: 19852993
[TBL] [Abstract][Full Text] [Related]
10. Regulation of psychostimulant-induced preprodynorphin, c-fos and zif/268 messenger RNA expression in the rat dorsal striatum by mu opioid receptor blockade.
Horner KA; Keefe KA
Eur J Pharmacol; 2006 Feb; 532(1-2):61-73. PubMed ID: 16443216
[TBL] [Abstract][Full Text] [Related]
11. Regulation of DARPP-32 phosphorylation by Delta9-tetrahydrocannabinol.
Borgkvist A; Marcellino D; Fuxe K; Greengard P; Fisone G
Neuropharmacology; 2008 Jan; 54(1):31-5. PubMed ID: 17686497
[TBL] [Abstract][Full Text] [Related]
12. Activation of the cAMP/PKA/DARPP-32 signaling pathway is required for morphine psychomotor stimulation but not for morphine reward.
Borgkvist A; Usiello A; Greengard P; Fisone G
Neuropsychopharmacology; 2007 Sep; 32(9):1995-2003. PubMed ID: 17251906
[TBL] [Abstract][Full Text] [Related]
13. Modification of mu-opioid agonist-induced locomotor activity and development of morphine dependence by diabetes.
Kamei J; Ohsawa M; Saitoh A; Iwamoto Y; Suzuki T; Misawa M; Nagase H; Kasuya Y
J Pharmacol Exp Ther; 1995 Aug; 274(2):700-6. PubMed ID: 7636731
[TBL] [Abstract][Full Text] [Related]
14. Effects of electroconvulsive shock on the phosphorylation of DARPP-32 in rat striatum.
Park HJ; Cui FJ; Roh JW; Jung YC; Kim SH; Kim YS; Kang UG
Psychiatry Res; 2009 Nov; 170(1):91-5. PubMed ID: 19818513
[TBL] [Abstract][Full Text] [Related]
15. Methamphetamine-induced locomotor activity and behavioral sensitization: are dopamine d3 receptors involved?
Jones CD; Bartee JA; Leite-Browning ML; Blackshear MA
Cell Mol Biol (Noisy-le-grand); 2007 May; 53(4):15-22. PubMed ID: 17531156
[TBL] [Abstract][Full Text] [Related]
16. Mu-opioid receptors are not involved in acute cocaine-induced locomotor activity nor in development of cocaine-induced behavioral sensitization in mice.
Lesscher HM; Hordijk M; Bondar NP; Alekseyenko OV; Burbach JP; van Ree JM; Gerrits MA
Neuropsychopharmacology; 2005 Feb; 30(2):278-85. PubMed ID: 15257307
[TBL] [Abstract][Full Text] [Related]
17. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
Baker AK; Meert TF
J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
[TBL] [Abstract][Full Text] [Related]
18. mu-Opioid receptor knockout mice are insensitive to methamphetamine-induced behavioral sensitization.
Shen X; Purser C; Tien LT; Chiu CT; Paul IA; Baker R; Loh HH; Ho IK; Ma T
J Neurosci Res; 2010 Aug; 88(10):2294-302. PubMed ID: 20209629
[TBL] [Abstract][Full Text] [Related]
19. Disruption of striatal glutamatergic/GABAergic homeostasis following acute methamphetamine in mice.
Pereira FC; Cunha-Oliveira T; Viana SD; Travassos AS; Nunes S; Silva C; Prediger RD; Rego AC; Ali SF; Ribeiro CA
Neurotoxicol Teratol; 2012; 34(5):522-9. PubMed ID: 22884891
[TBL] [Abstract][Full Text] [Related]
20. Mithramycin protects against dopaminergic neurotoxicity in the mouse brain after administration of methamphetamine.
Hagiwara H; Iyo M; Hashimoto K
Brain Res; 2009 Dec; 1301():189-96. PubMed ID: 19748494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
